Novolin R
NDC 0169-3003, Human Insulin, injection, solution, from Novo Nordisk.
- Product NDC
- 0169-3003
- Status
- Listed
- Labeler
- Novo Nordisk
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN OTC DRUG
- Marketing category
- BLA
- Application
- BLA019938
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0169-3003 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INSULIN HUMAN100 [iU]/mL
Pharmacologic classes
Insulin [CS]; Insulin [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0169-3003-15 | 00169300315 | 5 SYRINGE, PLASTIC in 1 CARTON (0169-3003-15) / 3 mL in 1 SYRINGE, PLASTIC (0169-3003-01) |
| 0169-3003-25 | 00169300325 | 5 SYRINGE, PLASTIC in 1 CARTON (0169-3003-25) / 3 mL in 1 SYRINGE, PLASTIC (0169-3003-12) |
Linked data
RxNorm, label and prices
Related lookups
NADAC price for package 00169300315
GET /v1/drugs/nadac/00169300315
Use it
Look up 0169-3003 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0169-3003 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0169-3003. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.